Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
Jingjing Cai, Meng Xu, Xiao‐Jing Zhang, et al.
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 14, Iss. 1, pp. 153-184
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease
Ze Chen, Ruifeng Tian, Zhi‐Gang She, et al.
Free Radical Biology and Medicine (2020) Vol. 152, pp. 116-141
Open Access | Times Cited: 935
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
Jianghua Zhou, Jingjing Cai, Zhi‐Gang She, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 11, pp. 1307-1326
Open Access | Times Cited: 207
Nonalcoholic Fatty Liver Disease
Yan-Ci Zhao, Guojun Zhao, Ze Chen, et al.
Hypertension (2019) Vol. 75, Iss. 2, pp. 275-284
Open Access | Times Cited: 188
The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis
Jingjing Cai, Xiao‐Jing Zhang, Hongliang Li
Hepatology (2019) Vol. 70, Iss. 3, pp. 1026-1037
Closed Access | Times Cited: 174
Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases
Jingjing Cai, Xiaojing Zhang, Yan‐Xiao Ji, et al.
Circulation Research (2020) Vol. 126, Iss. 5, pp. 679-704
Open Access | Times Cited: 151
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease
Wenxin Wang, Manli Hu, Hui Liu, et al.
Cell Metabolism (2021) Vol. 33, Iss. 10, pp. 1943-1956.e2
Closed Access | Times Cited: 126
Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway
Tian Lan, Yu Yang, Jing Zhang, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 686-703
Open Access | Times Cited: 113
Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications
Ola Elazazy, Heba M. Midan, Reem K. Shahin, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154512-154512
Closed Access | Times Cited: 49
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
Chongshu Jian, Jiajun Fu, Xu Cheng, et al.
Cell Metabolism (2020) Vol. 31, Iss. 5, pp. 892-908.e11
Open Access | Times Cited: 135
COVID‐19 and non‐alcoholic fatty liver disease: Two intersecting pandemics
Piero Portincasa, Marcin Krawczyk, Wiktor Smyk, et al.
European Journal of Clinical Investigation (2020) Vol. 50, Iss. 10
Open Access | Times Cited: 134
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 8, pp. 2648-2648
Open Access | Times Cited: 126
Emerging Molecular Targets for Treatment of Nonalcoholic Fatty Liver Disease
Ze Chen, Yao Yu, Jingjing Cai, et al.
Trends in Endocrinology and Metabolism (2019) Vol. 30, Iss. 12, pp. 903-914
Closed Access | Times Cited: 105
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5375-5375
Open Access | Times Cited: 92
Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder
Junjian Hu, Hongwu Wang, Xitang Li, et al.
Theranostics (2020) Vol. 10, Iss. 21, pp. 9702-9720
Open Access | Times Cited: 76
Nonalcoholic Fatty Liver Disease: An Emerging Driver of Cardiac Arrhythmia
Ze Chen, Jiayi Liu, Feng Zhou, et al.
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1747-1765
Open Access | Times Cited: 76
Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1
Lin Wang, Xin Zhang, Zhibin Lin, et al.
Cell Metabolism (2021) Vol. 33, Iss. 7, pp. 1372-1388.e7
Open Access | Times Cited: 71
Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species
Xiao‐Jing Zhang, Xiaolan Liu, Manli Hu, et al.
Cell Metabolism (2021) Vol. 33, Iss. 10, pp. 2059-2075.e10
Open Access | Times Cited: 56
NAFLD: An Emerging Causal Factor for Cardiovascular Disease
Mei Li, Horng‐Dar Wang, Xiao‐Jing Zhang, et al.
Physiology (2023) Vol. 38, Iss. 6, pp. 255-265
Closed Access | Times Cited: 24
Atherosclerotic Cardiovascular Diseases in Middle Delta of Egypt: A Systematic Analysis of Risk Factors Associated with the Rising Burden of the Disease
Mohamed Khalfallah, M Habib, Ahmed Mustafa Kishk, et al.
Global Heart (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Immunity as Cornerstone of Non-Alcoholic Fatty Liver Disease: The Contribution of Oxidative Stress in the Disease Progression
Marcello Dallio, Moris Sangineto, Mario Romeo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 1, pp. 436-436
Open Access | Times Cited: 55
Nonalcoholic Fatty Liver Disease and Cardiac Remodeling Risk: Pathophysiological Mechanisms and Clinical Implications
Jianghua Zhou, Lan Bai, Xiaojing Zhang, et al.
Hepatology (2021) Vol. 74, Iss. 5, pp. 2839-2847
Closed Access | Times Cited: 55
Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate–Activated Protein Kinase Signaling Pathway
Juan Wan, Yanyan Zhang, Diqi Yang, et al.
Hepatology (2021) Vol. 74, Iss. 6, pp. 3074-3090
Closed Access | Times Cited: 55
Research progress on Toll-like receptor signal transduction and its roles in antimicrobial immune responses
Pengpeng Xia, Yunping Wu, Siqi Lian, et al.
Applied Microbiology and Biotechnology (2021) Vol. 105, Iss. 13, pp. 5341-5355
Open Access | Times Cited: 50
Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy
Ze Chen, Zhaoxia Jin, Jingjing Cai, et al.
Journal of Molecular Medicine (2022) Vol. 100, Iss. 12, pp. 1721-1739
Closed Access | Times Cited: 30
Signaling pathways in uric acid homeostasis and gout: From pathogenesis to therapeutic interventions
Shuangling Yang, Haimei Liu, Xian-Ming Fang, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111932-111932
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top